

Author: Pascual Julio Diener Hans-Christoph
Publisher: Informa Healthcare
ISSN: 1473-4877
Source: Current Medical Research and Opinion, Vol.23, Iss.10, 2007-10, pp. : 2433-2440
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Public Drug Coverage and Its Impact on Triptan Use Across Canada: A Population‐Based Study
HEADACHE, Vol. 55, Iss. S4, 2015-07 ,pp. :






Individual Triptan Selection in Migraine Attack Therapy
Recent Patents on CNS Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. :


Pregnancy Outcome Following Prenatal Exposure to Triptan Medications: A Meta‐Analysis
HEADACHE, Vol. 55, Iss. 4, 2015-04 ,pp. :